Purchase Order 68HE0B26P0220
- Not listed
- Illumina, Inc. was awarded a $78,115 firm fixed-price purchase order by the Office of Acquisitions and Grants on January 12, 2023, for maintenance support services on a MiSeq M06789 sequencing instrument. The contract establishes a base period plus four option years, with an ultimate completion date of February 22, 2028. The award includes an estimated annual uplift of 4% applied at each option year exercise, with pricing adjusted downward if manufacturer list prices decrease below quoted...
- This is a firm fixed-price purchase order awarded by the Office of Acquisitions and Grants, a civilian agency, to Illumina, Inc., a manufacturer of genomic sequencing instruments and solutions. The contract is for $71,643.00 to provide service maintenance for an Illumina MiSeq sequencer. The award has no set-aside designation and the period of performance runs through June 10, 2024. Illumina has a history of providing sequencing systems and related services to various government agencies,...
- The Food and Drug Administration awarded a firm fixed-price purchase order to Illumina, Inc. for an annual maintenance agreement covering seven Illumina sequencing instruments, with a base year and four option years. The contract has a ceiling value of $817,521.04 and extends through March 23, 2029, with performance to be conducted in Laurel, Maryland. This maintenance agreement provides preventive maintenance, calibration, and repair services essential to keeping FDA's genomic sequencing...
- This federal contract award is a delivery order valued at $32,965.28 issued by a civilian federal agency to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The contract provides full coverage for parts, labor, and travel; reagent replacement upon hardware failures; preventative maintenance; remote technical support; on-site response within 2 business days; and hardware/software updates and on-site applications support. This contract is for a one-year...
- This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The contract, valued at $66,483.01, is for a Preventive Maintenance and Repair Agreement for an Illumina MiSeq system. The contract has an ultimate completion date of May 16, 2025 and does not utilize any set-aside designations. Illumina has been awarded numerous prime federal contracts and grants...
- This is a firm fixed-price delivery order awarded by the Animal and Plant Health Inspection Service (APHIS), a civilian agency within the U.S. Department of Agriculture, to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The contract is for preventative maintenance of Illumina's laboratory devices, with a ceiling value of $117,082.94 and a performance period ending on May 18, 2026. The contract is not set aside for any specific business type....
- This is a firm fixed-price delivery order contract awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Illumina, Inc., a for-profit manufacturer of genomic sequencing technologies. The contract is for $12,450.00 to provide preventative maintenance services for Illumina's MISEQ sequencing system. The contract has an ultimate completion date of June 30, 2018 and does not utilize any set-aside designations. Illumina, headquartered in San Diego, California, is a...
- The U.S. General Services Administration's Office of Administrative Services Procurement Management Branch awarded a $50,596.30 firm fixed price purchase order to Illumina, Inc. on May 11, 2016, for Illumina maintenance services with an ultimate completion date of January 1, 2018. The contract, which carries no set-aside designation, will be performed in Athens, Georgia. Illumina, Inc., a San Diego-based biotechnology company specializing in genetic sequencing and genomic analysis...
- This is a firm fixed-price delivery order awarded by the Animal and Plant Health Inspection Service, a civilian agency within the U.S. Department of Agriculture, to Illumina, Inc., a manufacturer of sequencing and analytical instruments and reagents. The $14,562.62 award is for the renewal of a service contract to provide maintenance and support for Illumina's MiSeq sequencing equipment. The order has a period of performance through July 29, 2024 and does not include any set-aside...
- Illumina, Inc. has been awarded a delivery order valued at $34,745.64 for the renewal of service contract on Illumina Tecan equipment. This firm fixed-price contract, awarded on September 10, 2025, will continue through September 9, 2026, and is being funded by a civilian federal agency within the Northeast Area. The work will be performed at a facility in Calverton, Maryland. The contract does not utilize any set-aside designation, reflecting Illumina's specialized capabilities in providing...
Illumina, Inc. has been awarded an Annual Service Maintenance Agreement valued at $16,684.00 by the Office of Research and Development, a civilian federal agency. This firm fixed-price purchase order, issued on February 25, 2026, will be performed in San Diego, California, with an ultimate completion date of March 1, 2027. The contract represents a maintenance service engagement typical of Illumina's broader federal portfolio, which encompasses support for the company's advanced genetic sequencing and genomic analysis platforms widely deployed across federal research institutions. This award reflects Illumina's established role as a critical technology provider within the federal research ecosystem. The contractor maintains a substantial Indefinite Delivery Indefinite Quantity contract with the U.S. Department of Agriculture valued at $45 million through June 2030, along with comparable vehicles and task orders across the National Institutes of Health, Department of Veterans Affairs, Defense Health Agency, and other civilian agencies. The maintenance agreement demonstrates the ongoing operational demands associated with Illumina's sequencing instrumentation and the company's position as a primary source for genomic research capabilities supporting federal scientific initiatives across infectious disease research, cancer diagnostics, agricultural genetic analysis, and related applications.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Service Maintenance Agreement | 68HE0B260032 | Environmental Protection Agency Office of Research and Development | Award Notice 1/1 | 2/25/26, 6:00 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.7k | 2/24/26 |